The DOI matches its Crossref record.
The UK Fleming Fund: Developing AMR surveillance capacity in low- and middle-income countries
Open accessAbstract
Background: The Fleming Fund is a UK Overseas Development Aid programme aiming to improve Antimicrobial Resistance (AMR) surveillance in low-and middle-income countries in Africa and Asia. The Fund has placed Country Grants in over 20 countries, to support implementation of the surveillance component of country AMR National Action Plans. Grants provide funding and technical assistance to develop AMR governance systems, and to improve capacity for bacteriology diagnostics, AMR reporting and data analysis. In rolling out the programme, we have accumulated a substantial dataset on AMR surveillance capacity across a broad range of settings. Methods and materials: As part of the grant placement process, we undertook a series of visits to each country to assess their AMR surveillance system and identify gaps which could be filled by the programme. Visits followed a standardised approach, which included meetings with AMR coordination committees, Ministries of Health, Agriculture, Fisheries and the Environment, FAO and WHO, and other relevant AMR stakeholders. The visits reviewed the sectors involved in AMR surveillance, the governance structure, national policies and strategies, key actors and activities, and barriers to implementation of National Action Plans. Results: Although countries varied in the maturity of their AMR surveillance systems, none had a fully functioning, integrated system. Common factors preventing implementation of surveillance were: a lack of coherent governance systems, lack of clarity regarding roles and responsibilities of different ministries, budget constraints, lack of technical expertise in surveillance design and data analysis, and poor IT and reporting systems. Conversely, we found differences in the rapidity of implementation, often related to the complexity of clinical and public health service governance. Conclusion: We have developed a comprehensive approach to assessing country capacity for AMR surveillance. Whilst the majority of countries have developed National Action Plans for AMR, implementation is universally hampered by lack of funding, poor inter-ministerial coordination, and limited technical expertise. Systematic identification of these issues will enable the Fleming Fund to adapt its programme to a wide range of situations and levels of capacity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In several SSA countries, including Kenya, the Fleming Fund 195 has greatly facilitated the implementation of the NAPs, especially raising awareness, ensuring an expanded antimicrobial stewardship framework to optimize antimicrobial use, increase AMR and antimicrobial use surveillance, monitoring, and data sharing, and the implementation of infection control and prevention strategies.”
From Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now? (2022) · cites this paper as [195]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Still being checked.
Cited by
Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?
Kariuki, S., Kering, K., Wairimu, C., Onsare, R., & Mbae, C. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s342753 · Cited by 245
Metadata
- Authors
- Gordon, N., Aggarwal, V., Amos, B., Buhler, C., Huszar, A., McKenzie, J., Mitchell, J., Moyen, N., Mubangizi, P., & Leslie, T.
- Affiliations
- Mott MacDonald (United Kingdom) (GB)
- Massey University (NZ)
- Corresponding author
- Gordon, N.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 101
- Pages
- 40
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W3125739576
- Cited by
- 12
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 1 · 2022: 1
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Keywords
- antimicrobial resistance surveillance, low- and middle-income countries, AMR governance, inter-ministerial coordination, technical assistance, development aid, implementation barriers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The UK Fleming Fund: Developing AMR surveillance capacity in low- and middle-income countries. https://app.cochat.ai/papers/10.1016/j.ijid.2020.09.137
- The paper
- Gordon, N., Aggarwal, V., Amos, B., Buhler, C., Huszar, A., McKenzie, J., Mitchell, J., Moyen, N., Mubangizi, P., & Leslie, T. (2020). The UK Fleming Fund: Developing AMR surveillance capacity in low- and middle-income countries. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2020.09.137